UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Opening Lecture: Novel Treatment Algorithms in Axial Spondyloarthritis — What is the Current Status?

Journal of clinical rheumatology and immunology (Online), 2023-11, Vol.23 (Supp01), p.9-9

BARALIAKOS, Xenofon

2023

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

The New England journal of medicine, 2015-12, Vol.373 (26), p.2534-2548

2015

Link zum Volltext

Verfügbarkeit prüfen

Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Nature reviews. Rheumatology, 2021-09, Vol.17 (9), p.565-576

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial II

Revista argentina de reumatologiá (Buenos Aires, Argentina : 1990), 2020-03, Vol.31 (1), p.2

Baraliakos, Xenofon

2020

Link zum Volltext

Verfügbarkeit prüfen

New developments in ankylosing spondylitis—status in 2021

Rheumatology (Oxford, England), 2021-12, Vol.60 (Supplement_6), p.vi29-vi37

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment

Arthritis research & therapy, 2022-08, Vol.24 (1), p.1-195, Article 195

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1958-1963

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Annals of the rheumatic diseases, 2023-01, Vol.82 (1), p.130

2023

Link zum Volltext

Verfügbarkeit prüfen

Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellence

Clinical rheumatology, 2021-11, Vol.40 (11), p.4759-4766

2021

Link zum Volltext

Verfügbarkeit prüfen

Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis

Scientific reports, 2022-04, Vol.12 (1), p.5985-5985, Article 5985

2022

Link zum Volltext

Verfügbarkeit prüfen

The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients

Journal of rheumatology, 2009-05, Vol.36 (5), p.997

2009

Link zum Volltext

Verfügbarkeit prüfen

Dose tapering of biologic agents in patients with rheumatoid arthritis—results from a cohort study in Germany

Clinical rheumatology, 2021-03, Vol.40 (3), p.887-893

2021

Link zum Volltext

Verfügbarkeit prüfen

Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference?

Journal of rheumatology, 2015-01, Vol.42 (1), p.31

2015

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence

Therapeutic Advances in Musculoskeletal Disease, 2021, Vol.13, p.1759720-1759720X211041854

2021

Link zum Volltext

Verfügbarkeit prüfen

Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review

Therapeutic Advances in Musculoskeletal Disease, 2020, Vol.12, p.1759720X20906040-1759720X20906040

2020

Link zum Volltext

Verfügbarkeit prüfen

Tapering bDMARDs in axial SpA - what is the current evidence?

Nature reviews. Rheumatology, 2019-06, Vol.15 (6), p.322-324

2019

Link zum Volltext

Verfügbarkeit prüfen

Treat to Target in Axial Spondyloarthritis

Rheumatic diseases clinics of North America, 2019-11, Vol.45 (4), p.519

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

BMC musculoskeletal disorders, 2021-12, Vol.22 (1), p.1037-1037, Article 1037

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-172, Article 172

2023

Link zum Volltext

Verfügbarkeit prüfen

Imaging Scoring Methods in Axial Spondyloarthritis

Rheumatic diseases clinics of North America, 2016-11, Vol.42 (4), p.663

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Acta dermato-venereologica, 2022-04, Vol.102, p.adv00698-adv00698

2022

Link zum Volltext

Verfügbarkeit prüfen

Addressing the spread of health-related misinformation on social networks: an opinion article

Frontiers in medicine, 2023-05, Vol.10, p.1167033-1167033

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X221093760-1759720X221093760

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 390

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(305)

Publikationsform

Artikel
(371)
Buchkapitel
(16)
Bücher
(2)
Berichte
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(296)
Life Sciences & Biomedicine
(294)
Rheumatology
(271)
Humans
(210)
Ankylosing Spondylitis
(118)
Arthritis
(94)
Female
(84)
Magnetic Resonance Imaging
(84)
Male
(84)
Patients
(76)
Inflammation
(73)
Adult
(71)
Spondyloarthritis
(70)
Axial Spondyloarthritis
(67)
Spondylitis, Ankylosing - Drug Therapy
(65)
Middle Aged
(59)
Rheumatic Diseases
(58)
Inflammatory Diseases
(46)
Severity Of Illness Index
(42)
Treatment Outcome
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Opening Lecture: Novel Treatment Algorithms in Axial Spondyloarthritis — What is the Current Status?

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Editorial II

New developments in ankylosing spondylitis—status in 2021

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellence

Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients

Dose tapering of biologic agents in patients with rheumatoid arthritis—results from a cohort study in Germany

Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference?

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence

Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review

Tapering bDMARDs in axial SpA - what is the current evidence?

Treat to Target in Axial Spondyloarthritis

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

Imaging Scoring Methods in Axial Spondyloarthritis

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Addressing the spread of health-related misinformation on social networks: an opinion article

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD

Suchergebnisse filtern